Immune therapy to restore ovary function and fertility
Treatments studied
Part of Immune system & allergy, Women’s health & pregnancy clinical trials.
This trial tests whether an immune-modulating drug can restart ovulation and improve fertility in women whose ovaries stopped working due to autoimmune disease. It is for women ages 18–38 with autoimmune premature ovarian insufficiency and certain antibodies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have written consent to join the study
- You are between 18 and 38 years old
- You have autoimmune premature ovarian insufficiency (periods stopped for at least 4 months, high FSH hormone levels, and antibodies to 21-hydroxylase or other related autoantibodies)
- Your body mass index (BMI) is between 19 and 30
- You are willing to use effective non-hormonal birth control during the 18-month study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests rituximab (an immune system medicine) to see if it can reduce OCD symptoms and/or psychosis when there are signs the immune system may be involved. You may be considered if other standard psychiatric treatments have not helped enough and your illness seems relatively recent with possible inflammation clues.
This study tests an experimental drug called YB-1113 for women with premature ovarian insufficiency (early menopause). The goal is to help your ovaries work better so you may become fertile. It is an early-stage trial focusing on safety and how well the drug works.
This trial tests whether injecting your own PRP (platelet-rich plasma) into the ovaries can improve ovarian function in some menopausal women. It may help those whose menopause seems less advanced, but not everyone will be eligible based on health and test results.
This trial studies whether an injection of your own PRP (platelet-rich plasma) can improve how your ovaries work in people with early ovarian failure. If it helps, it may lead to better hormone balance and return of more regular ovulation and periods.
This trial studies whether a “mechanical stimulation” procedure can help small egg-making structures in the ovary start to work again in people with primary ovarian insufficiency. If the procedure shows signs of response, you may then move on to further fertility treatment, including IVF.
This trial tests whether a hormone injection called HCG can activate dormant egg follicles in women under 40 who have gone through premature ovarian insufficiency (POI). If successful, it may help these women conceive.
Hear when a new Autoimmune Prematur Ovarian Insuffience trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.